BlossomHill Therapeutics, Inc. (BLSM) KPIs and segments
BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$15.13+1.48 (+10.84%)
Close on Nov 17, 2026Market cap $38.56MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive BlossomHill Therapeutics's business
Coming soon
This tab will track the numbers specific to BlossomHill Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?